Researchers from Vanderbilt and Columbia Universities and the FDA find that, through a retrospective cohort study of 28,858 patients of the Tennessee Medicaid program (and 14,429 controls), that children and youth exposed to antipsychotics had a 3-fold risk of developing type 2 diabetes during the first year of follow-up. The risk increased with cumulative dose, and remained elevated for one year following discontinuation. Results appeared online yesterday in JAMA Psychiatry.
Bobo, W., Cooper, W., Stein, M., Olfson, M., et al; Antipsychotics and the Risk of Type 2 Diabetes Mellitus in Children and Youth. JAMA Psychiatry. Online August 21, 2013
Of further interest:
Antipsychotic Medications Lead To Diabetes In Adolescents: Study (Pentagon Post)
Antipsychotic drugs raise diabetes risk for young people, Vanderbilt study shows (The Tennessean)
Antipsychotics triple risk of type 2 diabetes in young people (Clinical Psychiatry News)
Antipsychotic drug use in children for mood, behavior disorders increases type 2 diabetes risk (Medical Xpress)
Antipsychotic Drugs May Triple Kids’ Diabetes Risk (Web MD)